XS
AGN

XR Securities’s Allergan plc AGN Stock Holding History

XR Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,147
Closed -$713K – 384
2019
Q1 		$754K Sell
5,147
-730
-12% -$106K 0.1% 54
2018
Q4 		$786K Sell
5,877
-6,706
-53% -$1.1M 0.34% 39
2018
Q3 		$2.4M Sell
12,583
-2,131
-14% -$391K 0.63% 20
2018
Q2 		$2.45M Buy
+14,714
New +$2.36M 0.87% 13

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

XR Securities's AGN Position: Q2 2019 in Review

XR Securities sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 5,147 shares — an estimated $713K sold.

XR Securities first reported a position in AGN in Q2 2018 and held it in 4 quarters. The position peaked at $2.45M in Q2 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • XR Securities reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • XR Securities sold 5,147 Allergan plc shares in Q2 2019, an estimated $713K.
  • XR Securities first reported a position in Allergan plc in Q2 2018 and held it in 4 quarters.
  • XR Securities's Allergan plc position peaked at $2.45M in Q2 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on XR Securities's 13F filing for Q2 2019, filed 10 Jul 2019.